Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Medical News Today2d
Weight-loss surgery may preserve kidney health more effectively than GLP-1 drugs
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
Ticker: WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...